Moreover, JGXZ treatment attenuated the inflammatory response in NAFLD model rats, manifesting as mild lobular liver inflammation and reduced expression of proinflammatory cytokines (IL-6, IL-1β, and TNF-α) in the serum and liver. Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.